ICD-10-CM/PCS MS-DRG v38.0 R1 Definitions Manual |
||||
Skip to content |
Pre-MDC |
Chimeric antigen receptor (CAR) T-cell immunotherapy |
DRG |
---|
018 |
DRG 018 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL IMMUNOTHERAPY
T-CELL IMMUNOTHERAPY
NON-OPERATING ROOM PROCEDURES
XW033C3* | Introduction of Engineered Autologous Chimeric Antigen Receptor T-cell Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 3 |
XW043C3* | Introduction of Engineered Autologous Chimeric Antigen Receptor T-cell Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 3 |
XW23346* | Transfusion of Brexucabtagene Autoleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 6 |
XW23376* | Transfusion of Lisocabtagene Maraleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 6 |
XW24346* | Transfusion of Brexucabtagene Autoleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 6 |
XW24376* | Transfusion of Lisocabtagene Maraleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 6 |
Centers for Medicare & Medicaid Services, 7500 Security Boulevard Baltimore, MD 21244 17 Sep 2020 09:49:17 CMS, code-revision=275, description-revision=1286 |